Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression
, , , , , , , , and
Apr 13, 2022
About this article
Published Online: Apr 13, 2022
Page range: 427 - 436
Accepted: Jan 19, 2022
DOI: https://doi.org/10.2478/acph-2022-0029
Keywords
© 2022 Jiamin Du et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Du, Jiamin
Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Qian, Meijia
Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Yuan, Tao
Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Zhang, Bo
Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of MedicineHangzhou, China
Chen, Xueqin
Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People´s Hospital, Zhejiang University School of MedicineHangzhou, China
An, Ning
Department of Pharmacy, Ningbo Medical Center Lihuili HospitalNingbo, China
He, Qiaojun
Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Yang, Bo
Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Ye, Song
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Second Affiliated Hospital, School of Medicine Zhejiang UniversityHangzhou, China
Zhu, Hong
Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of MedicineHangzhou, China
The Westlake Laboratory of Life Sciences and BiomedicineHangzhou, China